{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:51:05Z","timestamp":1789426265343,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-03875-9","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T08:59:16Z","timestamp":1737622756000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Performance of the 2023 diagnostic criteria for MOGAD: real-world application in a Chinese multicenter cohort of pediatric and adult patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Meng-Ting","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Yao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Feng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"3","key":"3875_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1474-4422(22)00520-8","volume":"22","author":"F Graus","year":"2023","unstructured":"Graus F, Dalmau J. MOGAD comes of age with new criteria. Lancet Neurol. 2023;22(3):193\u20134.","journal-title":"Lancet Neurol"},{"issue":"7","key":"3875_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/1352458519845112","volume":"26","author":"CL de Mol","year":"2020","unstructured":"de Mol CL, Wong Y, van Pelt ED, Wokke B, Siepman T, Neuteboom RF, Hamann D, Hintzen RQ. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler. 2020;26(7):806\u201314.","journal-title":"Mult Scler"},{"issue":"11","key":"3875_CR3","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS Lopez-Chiriboga","year":"2018","unstructured":"Lopez-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, et al. Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol. 2018;75(11):1355\u201363.","journal-title":"JAMA Neurol"},{"issue":"1","key":"3875_CR4","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(1):134.","journal-title":"J Neuroinflammation."},{"key":"3875_CR5","doi-asserted-by":"publisher","first-page":"103746","DOI":"10.1016\/j.msard.2022.103746","volume":"59","author":"M Levy","year":"2022","unstructured":"Levy M, Yeh EA, Hawkes CH, Lechner-Scott J, Giovannoni G. Implications of low-titer MOG antibodies. Mult Scler Relat Disord. 2022;59:103746.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"3875_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, Ramanathan S, Waters P, Tenembaum S, Graves JS, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268\u201382.","journal-title":"Lancet Neurol"},{"key":"3875_CR7","doi-asserted-by":"publisher","first-page":"105150","DOI":"10.1016\/j.msard.2023.105150","volume":"81","author":"M Alaboudi","year":"2024","unstructured":"Alaboudi M, Morgan M, Serra A, Abboud H. Utility of the 2023 international MOGAD panel proposed criteria in clinical practice: An institutional cohort. Mult Scler Relat Disord. 2024;81:105150.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"3875_CR8","doi-asserted-by":"publisher","first-page":"e200183","DOI":"10.1212\/NXI.0000000000200183","volume":"11","author":"M Forcadela","year":"2024","unstructured":"Forcadela M, Rocchi C, San Martin D, Gibbons EL, Wells D, Woodhall MR, Waters PJ, Huda S, Hamid S. Timing of MOG-IgG testing is key to 2023 MOGAD diagnostic criteria. Neurol Neuroimmunol Neuroinflamm. 2024;11(1):e200183.","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"13","key":"3875_CR9","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1177\/13524585231198754","volume":"29","author":"KH Kim","year":"2023","unstructured":"Kim KH, Kim SH, Park NY, Hyun JW, Kim HJ. Validation of the International MOGAD Panel proposed criteria. Mult Scler. 2023;29(13):1680\u20133.","journal-title":"Mult Scler."},{"key":"3875_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejpn.2024.01.006","volume":"49","author":"M Kurd","year":"2024","unstructured":"Kurd M, Pratt LT, Gilboa T, Fattal-Valevski A, Vaknin-Dembinsky A, Gadoth A, Hacohen Y, Meirson H. Validation of the 2023 international diagnostic criteria for MOGAD in a pediatric cohort. Eur J Paediatr Neurol. 2024;49:13\u20136.","journal-title":"Eur J Paediatr Neurol"},{"issue":"9","key":"3875_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2023-333227","volume":"95","author":"AG Filippatou","year":"2024","unstructured":"Filippatou AG, Said Y, Chen H, Vasileiou ES, Ahmadi G, Sotirchos ES. Validation of the international MOGAD panel proposed criteria: a single-centre US study. J Neurol Neurosurg Psychiatry. 2024;95(9):870\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"3875_CR12","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1007\/s00415-024-12438-6","volume":"271","author":"A Rechtman","year":"2024","unstructured":"Rechtman A, Freidman-Korn T, Zveik O, Shweiki L, Hoichman G, Vaknin-Dembinsky A. Assessing the applicability of the 2023 international MOGAD panel criteria in real-world clinical settings. J Neurol. 2024;271(8):5102\u20138.","journal-title":"J Neurol"},{"issue":"1","key":"3875_CR13","doi-asserted-by":"publisher","first-page":"e209321","DOI":"10.1212\/WNL.0000000000209321","volume":"103","author":"JA Varley","year":"2024","unstructured":"Varley JA, Champsas D, Prossor T, Pontillo G, Abdel-Mannan O, Khaleeli Z, Petzold A, Toosy AT, Trip SA, Wilson H, et al. Validation of the 2023 International diagnostic criteria for MOGAD in a selected cohort of adults and children. Neurology. 2024;103(1):e209321.","journal-title":"Neurology."},{"key":"3875_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jneuroim.2018.05.014","volume":"321","author":"L Chen","year":"2018","unstructured":"Chen L, Chen C, Zhong X, Sun X, Zhu H, Li X, Yang H, Shu Y, Chang Y, Hu X, et al. Different features between pediatric-onset and adult-onset patients who are seropositive for MOG-IgG: A multicenter study in South China. J Neuroimmunol. 2018;321:83\u201391.","journal-title":"J Neuroimmunol"},{"key":"3875_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ajo.2020.07.008","volume":"219","author":"T Padungkiatsagul","year":"2020","unstructured":"Padungkiatsagul T, Chen JJ, Jindahra P, Akaishi T, Takahashi T, Nakashima I, Takeshita T, Moss HE. Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race. Am J Ophthalmol. 2020;219:332\u201340.","journal-title":"Am J Ophthalmol"},{"key":"3875_CR16","doi-asserted-by":"publisher","first-page":"679430","DOI":"10.3389\/fneur.2021.679430","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Liu L, Xiong J, Zhang L, Huang P, Tang L, Xiao Y, Li X, Li J, Luo Y, et al. The clinical, radiologic, and prognostic differences between pediatric and adult patients with myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. Front Neurol. 2021;12:679430.","journal-title":"Front Neurol."},{"key":"3875_CR17","doi-asserted-by":"publisher","first-page":"104939","DOI":"10.1016\/j.msard.2023.104939","volume":"78","author":"M Gu","year":"2023","unstructured":"Gu M, Mo X, Fang Z, Zhang H, Lu W, Shen X, Yang L, Wang W. Characteristics of aseptic meningitis-like attack-an underestimated phenotype of myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord. 2023;78:104939.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"3875_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/jdn.10255","volume":"83","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Tan C, Li X, Jiang L, Hong S, Yuan P, Zheng H, Fan X, Han W. Clinical features of the first attack with leukodystrophy-like phenotype in children with myelin oligodendrocyte glycoprotein antibody-associated disorders. Int J Dev Neurosci. 2023;83(3):267\u201373.","journal-title":"Int J Dev Neurosci"},{"issue":"4","key":"3875_CR19","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/ene.14654","volume":"28","author":"J ZhangBao","year":"2021","unstructured":"ZhangBao J, Huang W, Zhou L, Wang L, Chang X, Lu C, Zhao C, Lu J, Quan C. Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: A comparative study in Chinese Han patients. Eur J Neurol. 2021;28(4):1308\u201315.","journal-title":"Eur J Neurol"},{"issue":"4","key":"3875_CR20","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1002\/ctd2.225","volume":"3","author":"EC Li","year":"2023","unstructured":"Li EC, Lai QL, Cai MT, Fang W, Ding MP, Zhang YX. Criteria for myelin oligodendrocyte glycoprotein antibody-associated disease: Balancing underdiagnosis with overdiagnosis. Clin Transl Discovery. 2023;3(4):e225.","journal-title":"Clin Transl Discovery"},{"issue":"8","key":"3875_CR21","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1007\/s00415-023-11737-8","volume":"270","author":"A Al-Ani","year":"2023","unstructured":"Al-Ani A, Chen JJ, Costello F. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol. 2023;270(8):4132\u201350.","journal-title":"J Neurol"},{"issue":"15","key":"3875_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1212\/WNL.0000000000207238","volume":"100","author":"O Ciccarelli","year":"2023","unstructured":"Ciccarelli O, Toosy AT, Thompson A, Hacohen Y. Navigating through the recent diagnostic criteria for MOGAD: challenges and practicalities. Neurology. 2023;100(15):689\u201390.","journal-title":"Neurology."},{"issue":"4","key":"3875_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3988\/jcn.2022.0433","volume":"19","author":"J Hwangbo","year":"2023","unstructured":"Hwangbo J, Oh SI. A case of MRI-negative encephalomyelitis in a patient with long-term stable myelin oligodendrocyte glycoprotein antibody-associated disease. J Clin Neurol. 2023;19(4):422\u20134.","journal-title":"J Clin Neurol."},{"issue":"11","key":"3875_CR24","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","volume":"92","author":"PJ Waters","year":"2019","unstructured":"Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology. 2019;92(11):e1250\u20135.","journal-title":"Neurology"},{"key":"3875_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-0716-1138-8_18","volume":"2249","author":"BJ Barrett","year":"2021","unstructured":"Barrett BJ, Fardy JM. Evaluation of diagnostic tests. Methods Mol Biol. 2021;2249:319\u201333.","journal-title":"Methods Mol Biol."},{"issue":"3","key":"3875_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.pop.2013.06.001","volume":"40","author":"K Putz","year":"2013","unstructured":"Putz K, Hayani K, Zar FA. Meningitis. Prim Care. 2013;40(3):707\u201326.","journal-title":"Prim Care"},{"issue":"2","key":"3875_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3875_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/cei\/uxad109","volume":"215","author":"BQ Du","year":"2024","unstructured":"Du BQ, Lai QL, Li EC, Cai MT, Fang GL, Shen CH, Zhang YX, Ding MP. Myelin oligodendrocyte glycoprotein antibody and N-methyl-d-aspartate receptor antibody overlapping syndrome: insights from the recent case reports. Clin Exp Immunol. 2024;215(1):27\u201336.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"3875_CR29","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jamaneurol.2023.3956","volume":"80","author":"P Lipps","year":"2023","unstructured":"Lipps P, Gomes ABAGR, Kulsvehagen L, Mutke MA, Kuhle J, Papadopoulou A, Probstel AK. Ongoing challenges in the diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease. JAMA Neurol. 2023;80(12):1377\u20139.","journal-title":"JAMA Neurol."},{"issue":"10","key":"3875_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41582-024-01005-2","volume":"20","author":"R Geraldes","year":"2024","unstructured":"Geraldes R, Arrambide G, Banwell B, Rovira A, Cortese R, Lassmann H, Messina S, Rocca MA, Waters P, Chard D, et al. The influence of MOGAD on diagnosis of multiple sclerosis using MRI. Nat Rev Neurol. 2024;20(10):620\u201335.","journal-title":"Nat Rev Neurol."},{"issue":"9","key":"3875_CR31","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1007\/s00415-024-12585-w","volume":"217","author":"GS Manzano","year":"2024","unstructured":"Manzano GS, Levy M, Salky R, Mateen FJ, Klawiter EC, Chitnis T, Vasileiou ES, Sotirchos ES, Gibbons E, Huda S, et al. Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypes. J Neurol. 2024;217(9):6160\u201371.","journal-title":"J Neurol"},{"key":"3875_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","volume":"29","author":"AL Bruijstens","year":"2020","unstructured":"Bruijstens AL, Lechner C, Flet-Berliac L, Deiva K, Neuteboom RF, Hemingway C, Wassmer E, consortium EUpM, Baumann M, Bartels F, et al. EU paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020;29:2\u201313.","journal-title":"Eur J Paediatr Neurol."},{"key":"3875_CR33","doi-asserted-by":"publisher","first-page":"104126","DOI":"10.1016\/j.msard.2022.104126","volume":"68","author":"S Lin","year":"2022","unstructured":"Lin S, Long W, Wen J, Su Q, Liao J, Hu Z. Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype. Mult Scler Relat Disord. 2022;68:104126.","journal-title":"Mult Scler Relat Disord"},{"key":"3875_CR34","doi-asserted-by":"publisher","first-page":"100552","DOI":"10.1016\/j.ejro.2024.100552","volume":"12","author":"M Abunada","year":"2024","unstructured":"Abunada M, Nierobisch N, Ludovichetti R, Simmen C, Terziev R, Togni C, Michels L, Kulcsar Z, Hainc N. Autoimmune encephalitis: Early and late findings on serial MR imaging and correlation to treatment timepoints. Eur J Radiol Open. 2024;12:100552.","journal-title":"Eur J Radiol Open"},{"issue":"4","key":"3875_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"5","key":"3875_CR36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/brain\/awaa102","volume":"143","author":"Y Takai","year":"2020","unstructured":"Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, Nishida H, Komori T, Seki M, Komatsu T, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020;143(5):1431\u201346.","journal-title":"Brain"},{"issue":"2","key":"3875_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ana.26279","volume":"91","author":"JA McCombe","year":"2022","unstructured":"McCombe JA, Flanagan EP, Chen JJ, Zekeridou A, Lucchinetti CF, Pittock SJ. Investigating the immunopathogenic mechanisms underlying MOGAD. Ann Neurol. 2022;91(2):299\u2013300.","journal-title":"Ann Neurol"},{"issue":"9469","key":"3875_CR38","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0140-6736(05)66422-7","volume":"365","author":"DA Grimes","year":"2005","unstructured":"Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005;365(9469):1500\u20135.","journal-title":"Lancet"},{"issue":"8","key":"3875_CR39","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1177\/13524585231172954","volume":"29","author":"M Reindl","year":"2023","unstructured":"Reindl M, Rostasy K. Serum MOG IgG titres should be performed routinely in the diagnosis and follow-up of MOGAD: Yes. Mult Scler. 2023;29(8):926\u20137.","journal-title":"Mult Scler."},{"key":"3875_CR40","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.2147\/NDT.S372446","volume":"18","author":"X Fan","year":"2022","unstructured":"Fan X, Li Q, Li T, He X, Feng C, Qin B, Xu Y, He L. Radiological features for outcomes of MOGAD in children: a cohort in Southwest China. Neuropsychiatr Dis Treat. 2022;18:1875\u201384.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3875_CR41","doi-asserted-by":"publisher","first-page":"1162647","DOI":"10.3389\/fimmu.2023.1162647","volume":"14","author":"X Li","year":"2023","unstructured":"Li X, Wu W, Hou C, Zeng Y, Wu W, Chen L, Liao Y, Zhu H, Tian Y, Peng B, et al. Pediatric myelin oligodendrocyte glycoprotein antibody-associated disease in southern China: analysis of 93 cases. Front Immunol. 2023;14:1162647.","journal-title":"Front Immunol"},{"issue":"10","key":"3875_CR42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/jnnp-2022-330901","volume":"94","author":"J ZhangBao","year":"2023","unstructured":"ZhangBao J, Huang W, Zhou L, Tan H, Wang L, Wang M, Yu J, Lu C, Lu J, Quan C. Clinical feature and disease outcome in patients with myelin oligodendrocyte glycoprotein antibody-associated disorder: a Chinese study. J Neurol Neurosurg Psychiatry. 2023;94(10):825\u201334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"3875_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/jnnp-2023-331137","volume":"95","author":"P Elsbernd","year":"2023","unstructured":"Elsbernd P, Cacciaguerra L, Krecke KN, Chen JJ, Gritsch D, Lopez-Chiriboga AS, Sechi E, Redenbaugh V, Morris PP, Carter JL, et al. Cerebral enhancement in MOG antibody-associated disease. J Neurol Neurosurg Psychiatry. 2023;95(1):14\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3875_CR44","doi-asserted-by":"publisher","first-page":"101452","DOI":"10.1016\/j.msard.2019.101452","volume":"37","author":"P Wildner","year":"2020","unstructured":"Wildner P, Stasiolek M, Matysiak M. Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases. Mult Scler Relat Disord. 2020;37:101452.","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"3875_CR45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jama.1994.03510330081039","volume":"271","author":"R Jaeschke","year":"1994","unstructured":"Jaeschke R, Guyatt GH, Sackett DL. Users\u2019 guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(9):703\u20137.","journal-title":"JAMA."},{"key":"3875_CR46","doi-asserted-by":"publisher","first-page":"1380541","DOI":"10.3389\/fneur.2024.1380541","volume":"15","author":"A Budhram","year":"2024","unstructured":"Budhram A, Rotstein DL, Yang L, Yeh EA. Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing. Front Neurol. 2024;15:1380541.","journal-title":"Front Neurol"},{"issue":"2","key":"3875_CR47","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","volume":"7","author":"M Reindl","year":"2020","unstructured":"Reindl M, Schanda K, Woodhall M, Tea F, Ramanathan S, Sagen J, Fryer JP, Mills J, Teegen B, Mindorf S, et al. International multicenter examination of MOG antibody assays. Neurol Neuroimmunol Neuroinflamm. 2020;7(2):e674.","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03875-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-03875-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03875-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T20:15:01Z","timestamp":1737663301000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-03875-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3875"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-03875-9","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the local ethics committee of each participating center (Second Affiliated Hospital, School of Medicine, Zhejiang University [approval number: 2024-LSY-0682], Children\u2019s Hospital, Zhejiang University\u00a0School of Medicine [approval number: 2024-IRB-0238-P-01], and Zhejiang Hospital [approval number: 2024-095K]). Patient consent was waived for this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}